A 
395
-9.40%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩16.90bn
FY2017FY2025
Net income
−₩23.43bn
FY2017FY2025
Free cash flow
−₩55.57bn
FY2017FY2025
Shareholders' equity
₩95.18bn
FY2017FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩16.90bn | ₩18.38bn | ₩20.42bn | ₩17.56bn | ₩25.13bn | ₩30.37bn | — | — | — |
| Research and development | ₩4.90bn | ₩5.06bn | ₩93.8m | ₩529.5m | ₩94.3m | ₩173.0m | — | — | — |
| Operating income | — | −₩19.21bn | −₩9.79bn | −₩3.14bn | −₩1.12bn | ₩1.13bn | −₩43.0m | −₩50.0m | −₩25.0m |
| Net income | −₩23.43bn | −₩19.17bn | −₩5.00bn | −₩3.25bn | −₩930.3m | −₩3.61bn | ₩64.0m | ₩47.0m | ₩4.0m |
| Diluted earnings per share | -1,191.88 | -120.70 | -38.30 | -29.44 | -9.94 | -128.78 | 12.80 | 9.40 | 1.33 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩160.06bn | ₩206.41bn | ₩98.56bn | ₩66.14bn | ₩36.26bn | ₩35.78bn | ₩9.59bn | ₩9.52bn | ₩9.45bn |
| Cash and short-term investments | — | ₩182.76bn | ₩66.68bn | ₩50.49bn | — | ₩14.48bn | ₩9.54bn | ₩9.45bn | ₩9.40bn |
| Total liabilities | ₩64.87bn | ₩125.49bn | ₩40.14bn | ₩23.78bn | ₩6.93bn | ₩5.57bn | ₩990.0m | ₩979.0m | ₩956.0m |
| Debt | — | ₩225.1m | ₩172.6m | ₩44.2m | — | ₩94.0m | ₩972.0m | ₩952.0m | ₩933.0m |
| Shareholders' equity | ₩95.18bn | ₩80.92bn | ₩58.43bn | ₩42.36bn | ₩29.33bn | ₩30.21bn | ₩8.60bn | ₩8.54bn | ₩8.49bn |
| Shares outstanding | 20m | 159m | 131m | 110m | 94m | 28m | 5m | 5m | 3m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩40.02bn | −₩10.23bn | −₩4.68bn | ₩1.15bn | ₩4.23bn | ₩1.46bn | — | ₩44.8m | −₩18.5m |
| Capital spending | −₩15.54bn | −₩510.5m | −₩4.18bn | −₩2.21bn | −₩23.7m | −₩85.1m | — | — | — |
| Free cash flow | −₩55.57bn | −₩10.74bn | −₩8.86bn | −₩1.06bn | ₩4.21bn | ₩1.37bn | — | ₩44.8m | −₩18.5m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩3.37bn | ₩4.54bn | ₩2.32bn | ₩5.17bn | ₩2.83bn | ₩6.57bn | ₩3.83bn | ₩4.40bn |
| Operating income | −₩1.30bn | −₩1.77bn | −₩3.63bn | — | −₩3.99bn | −₩2.50bn | −₩13.88bn | −₩1.90bn |
| Net income | −₩3.87bn | −₩13.22bn | −₩7.63bn | −₩4.27bn | −₩15.83bn | ₩9.37bn | −₩12.41bn | −₩2.68bn |
| Diluted earnings per share | -196.89 | -672.27 | -388.31 | -217.15 | -817.94 | 59.03 | -78.14 | -16.86 |
| Cash from operations | ₩1.25bn | −₩559.0m | −₩1.19bn | −₩1.51bn | −₩1.08bn | −₩36.25bn | −₩10.23bn | −₩3.27bn |
| Capital spending | −₩29.0m | −₩155.0m | −₩1.94bn | −₩12.78bn | −₩61.0m | −₩767.0m | −₩510.0m | −₩356.0m |
| Free cash flow | ₩1.22bn | −₩714.0m | −₩3.13bn | −₩14.28bn | −₩1.14bn | −₩37.02bn | −₩10.74bn | −₩3.63bn |
| Total assets | ₩151.77bn | ₩148.33bn | ₩160.06bn | ₩232.29bn | ₩236.16bn | ₩217.98bn | ₩206.41bn | ₩116.80bn |
| Cash and short-term investments | — | — | — | — | — | ₩75.70bn | ₩182.76bn | ₩87.79bn |
| Debt | — | — | — | — | — | ₩301.6m | ₩225.1m | ₩590.5m |
| Shareholders' equity | ₩78.91bn | ₩82.29bn | ₩95.18bn | ₩102.58bn | ₩103.04bn | ₩90.43bn | ₩80.92bn | ₩89.51bn |
Financial ratios
Data as of 18 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating margin | — | -104.5% | -48.0% | -17.9% | -4.5% |
| Net margin | -138.7% | -104.3% | -24.5% | -18.5% | -3.7% |
| Return on equity | -24.6% | -23.7% | -8.6% | -7.7% | -3.2% |
| Return on assets | -14.6% | -9.3% | -5.1% | -4.9% | -2.6% |
| Revenue growth | -8.1% | -10.0% | 16.2% | -30.1% | — |
| Earnings growth | 22.2% | 283.1% | 54.1% | 249.1% | — |
| Current ratio | 0.48x | 1.52x | 1.87x | 2.49x | 4.54x |
| Debt to equity | — | 0.00x | 0.00x | 0.00x | — |
| Equity ratio | 59.5% | 39.2% | 59.3% | 64.1% | 80.9% |
| Interest coverage | — | -6.91x | -2.88x | -58.42x | -194.25x |
| R&D as a share of sales | 29.0% | 27.5% | 0.5% | 3.0% | 0.4% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -1.3% | -11.1% | — |
| Net income | 93.2% | 45.4% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | -2.9 | -116.4 | -570.4 | -402.6 | -917.5 | -62.8 |
| Price to sales | 4.0 | 121.4 | 139.8 | 74.4 | 34.0 | 7.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 3-for-1 split · 13 Nov 2023
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.